AI Article Synopsis

  • A 60-year-old man with advanced rectal cancer underwent chemoradiotherapy and showed initial tumor shrinkage and symptom resolution.
  • After suspecting remnant cancer, he started a new chemotherapy regimen, mFOLFOX6, but had to stop due to side effects.
  • Ultimately, a complete clinical and pathological response was achieved with additional S-1 treatment over a year, and he has remained cancer-free for 6 years, indicating non-surgical treatment can be effective for this condition.

Article Abstract

A 60-year-old man with advanced rectal cancer and urinary bladder fistula received preoperative chemoradiotherapy with S-1(120mg/m / 2day)on weekdays and concurrent radiotherapy(65 Gy). After chemoradiotherapy, the clinical symptoms resolved and the tumor shrunk, as observed on endoscopic and radiologic examinations. However, remnant cancer was suspected; therefore, modified oxaliplatin, 5-fluorouracil, and Leucovorin(mFOLFOX6)therapy was initiated, although it was stopped after 3 cycles because of numbness in the lower extremities. Finally, clinical and pathological complete response(CR) was achieved by administering additional doses of S-1 for approximately 1 year after treatment initiation; CR was confirmed by using endoscopy and computed tomography(CT), and there has been no recurrence for 6 years. This case suggests that treatment without surgery is a viable alternative for advanced rectal cancer with pathological CR after chemoradiotherapy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

advanced rectal
12
rectal cancer
12
cancer urinary
8
urinary bladder
8
bladder fistula
8
case patient
4
patient advanced
4
cancer
4
fistula surviving
4
surviving years
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!